Cafepharma Today

June 4 2025 - Moderna will test new COVID shot against placebo, Robert F Kennedy Jr. says
Moderna will test new COVID shot against placebo, Robert F Kennedy Jr. says
Massachusetts’ life sciences job growth flattens after 10+ years of increases
CDC official overseeing COVID-19 vaccine recommendations resigns
Lilly inks deal worth up to $870M to develop long-acting GLP-1 obesity drugs
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Brother, Can You Spare A Prescription?
Pharmalot
Monday, October 18, 2010 - 3:07pm
tags:
economy, drug data, prescription data
Roche seeks OK for juvenile Actemra use
Fierce Pharma
Monday, October 18, 2010 - 1:42pm
tags:
Roche, pediatrics, Actemra, juvenile arthritis
Lexicon Pharmaceuticals Shares Popped: What You Need to Know
Motley Fool
Monday, October 18, 2010 - 1:38pm
tags:
Lexicon Pharmaceuticals
Glaxo Turns its Eye to ‘Bubble Boy Disease’ in Rare Disease Push
WSJ Online
Monday, October 18, 2010 - 1:37pm
tags:
GSK, ADA-SCID
Earnings Preview: Abbott Laboratories
Yahoo/AP
Monday, October 18, 2010 - 1:35pm
tags:
earnings, Abbott Laboratories
PharmAsiaSummit: Emerging Markets Are Growth, Growth, Growth, But Where's The Beef?
InVivo
Monday, October 18, 2010 - 11:12am
tags:
emerging markets, PharmAsiaSummit
Ista Pharmaceuticals gets FDA approval for Bromday eye drop, shares jump in morning trading
Yahoo/AP
Monday, October 18, 2010 - 11:10am
tags:
Ista, FDA, Bromday
Pfizer Goes Super-Generic
Forbes
Monday, October 18, 2010 - 11:09am
tags:
Pfizer, generics, insulin, Biocon, diabetes, M&A
Another Vytorin Trial And Changing Endpoints
Pharmalot
Monday, October 18, 2010 - 10:29am
tags:
Vytorin, Merck, Schering Plough
Lilly osteoporosis drug regrows jaw bone: study
Reuters, UK
Monday, October 18, 2010 - 10:28am
tags:
Eli Lilly, osteoporosis, Forteo
Analyzing Major Big Pharma Players Using Relative Valuation
Seeking Alpha
Monday, October 18, 2010 - 10:07am
tags:
Abbott Laboratories, Bristol-Myers Squibb, GSK, Eli Lilly, Merck, Novartis
Qiagen Inks Deal with Abbott
Yahoo/Zacks.com
Monday, October 18, 2010 - 10:03am
tags:
Abbott Laboratories, Qiagen, HIV
Gilead Sciences Earnings Preview
TheStreet.com
Monday, October 18, 2010 - 10:00am
tags:
Gilead Sciences, earnings
Pfizer Acquires Rights to Biocon Insulin Products for $200 Million Upfront
Bloomberg
Monday, October 18, 2010 - 9:54am
tags:
M&A, Pfizer, Biocon, insulin
China Biotech Week in Review: Good News From Pfizer, Roche
Seeking Alpha
Monday, October 18, 2010 - 9:53am
tags:
China, Roche, Pfizer, MingSight, OrbusNeich, Vital Therapies
Botox Migraine Approval May Gain Allergan $1 Billion in Sales
Bloomberg
Monday, October 18, 2010 - 9:42am
tags:
FDA, migraines, Botox, Allergan
A Look at AstraZeneca Price Targets
Seeking Alpha
Monday, October 18, 2010 - 9:41am
tags:
AstraZeneca
Exelixis Deepens Profitable Ties to BMS
Seeking Alpha
Monday, October 18, 2010 - 9:41am
tags:
Bristol-Myers Squibb, Exelixis, diabetes, partnerships
Eli Lilly Scraps Late-Stage Head and Neck Cancer Drug: Biotech's Latest Tribulations
Seeking Alpha
Sunday, October 17, 2010 - 11:57am
tags:
Eli Lilly, Alimta, squamous cell cancer, head and neck cancer
GfK HealthCare Study: Physicians Ready to Accept New Oral Therapy for MS
Trading Markets
Sunday, October 17, 2010 - 11:54am
tags:
multiple sclerosis, Gilenya, Novartis

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.